Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant—Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A)

Nicholas Brookhouser, Ping Zhang, Richard John Caselli, Jean J. Kim, David A. Brafman

Research output: Contribution to journalArticle

Abstract

Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human induced pluripotent stem cell (hiPSC) lines from the peripheral blood mononuclear cells (PBMCs) of a clinically diagnosed AD patient [ASUi005-A] and a non-demented control (NDC) patient [ASUi006-A] homozygous for the APOE4 risk allele. These hiPSCs maintained their original genotype, expressed pluripotency markers, exhibited a normal karyotype, and retained the ability to differentiate into cells representative of the three germ layers. Resource table [Table presented]

Original languageEnglish (US)
Pages (from-to)145-149
Number of pages5
JournalStem Cell Research
Volume32
DOIs
StatePublished - Oct 1 2018

Fingerprint

Apolipoprotein E4
Induced Pluripotent Stem Cells
Cell Line
Alzheimer Disease
Germ Layers
Aptitude
Apolipoproteins E
Karyotype
Blood Cells
Alleles
Genotype
Genes

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

@article{572f5a9de7be422591515fb45b861365,
title = "Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant—Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A)",
abstract = "Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human induced pluripotent stem cell (hiPSC) lines from the peripheral blood mononuclear cells (PBMCs) of a clinically diagnosed AD patient [ASUi005-A] and a non-demented control (NDC) patient [ASUi006-A] homozygous for the APOE4 risk allele. These hiPSCs maintained their original genotype, expressed pluripotency markers, exhibited a normal karyotype, and retained the ability to differentiate into cells representative of the three germ layers. Resource table [Table presented]",
author = "Nicholas Brookhouser and Ping Zhang and Caselli, {Richard John} and Kim, {Jean J.} and Brafman, {David A.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.scr.2018.09.007",
language = "English (US)",
volume = "32",
pages = "145--149",
journal = "Stem Cell Research",
issn = "1873-5061",
publisher = "Elsevier",

}

TY - JOUR

T1 - Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant—Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A)

AU - Brookhouser, Nicholas

AU - Zhang, Ping

AU - Caselli, Richard John

AU - Kim, Jean J.

AU - Brafman, David A.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human induced pluripotent stem cell (hiPSC) lines from the peripheral blood mononuclear cells (PBMCs) of a clinically diagnosed AD patient [ASUi005-A] and a non-demented control (NDC) patient [ASUi006-A] homozygous for the APOE4 risk allele. These hiPSCs maintained their original genotype, expressed pluripotency markers, exhibited a normal karyotype, and retained the ability to differentiate into cells representative of the three germ layers. Resource table [Table presented]

AB - Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human induced pluripotent stem cell (hiPSC) lines from the peripheral blood mononuclear cells (PBMCs) of a clinically diagnosed AD patient [ASUi005-A] and a non-demented control (NDC) patient [ASUi006-A] homozygous for the APOE4 risk allele. These hiPSCs maintained their original genotype, expressed pluripotency markers, exhibited a normal karyotype, and retained the ability to differentiate into cells representative of the three germ layers. Resource table [Table presented]

UR - http://www.scopus.com/inward/record.url?scp=85054253314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054253314&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2018.09.007

DO - 10.1016/j.scr.2018.09.007

M3 - Article

VL - 32

SP - 145

EP - 149

JO - Stem Cell Research

JF - Stem Cell Research

SN - 1873-5061

ER -